metformin

Recent Research News: Metformin May Reduce Cancer Death Risk

FRIDAY, April 15, 2016 (HealthDay News) — Metformin, a commonly prescribed diabetes drug, may reduce the risk of dying from some cancers for postmenopausal women with type 2 diabetes, a new study suggests.

The study found that for women with type 2 diabetes and cancer, the odds of dying from cancer appeared to be 45 percent higher compared to women with cancer who didn’t have diabetes. But, in women with cancer who took metformin to treat their type 2 diabetes, the risk of dying from cancer seemed about the same as it was for women without diabetes.

To read the full article, visit: https://www.nlm.nih.gov/medlineplus/news/fullstory_158338.html.

Leave a Reply

Your email address will not be published. Required fields are marked *